cyclooxygenase–a target for colon cancer prevention
RN Dubois - Alimentary Pharmacology & Therapeutics, 2000 - Wiley Online Library
Use of nonsteroidal anti‐inflammatory drugs such as aspirin, which are known to inhibit
cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40–50 …
cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40–50 …
cyclooxygenase-a target for colon cancer prevention.
RN Dubois - Alimentary Pharmacology & Therapeutics, 2000 - search.ebscohost.com
Use of nonsteroidal antiinflammatory drugs such as aspirin, which are known to inhibit
cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40–50 …
cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40–50 …
Cyclooxygenase-A target for colon cancer prevention
RN Dubois - Alimentary Pharmacology and Therapeutics …, 2000 - asu.elsevierpure.com
Use of nonsteroidal anti-inflammatory drugs such as aspirin, which are known to inhibit
cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40-50 …
cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40-50 …
cyclooxygenase--a target for colon cancer prevention
RN Dubois - Alimentary pharmacology & therapeutics, 2000 - pubmed.ncbi.nlm.nih.gov
Use of nonsteroidal anti-inflammatory drugs such as aspirin, which are known to inhibit
cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40-50 …
cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40-50 …
cyclooxygenase--a target for colon cancer prevention.
RN Dubois - Alimentary Pharmacology & Therapeutics, 2000 - europepmc.org
Use of nonsteroidal anti-inflammatory drugs such as aspirin, which are known to inhibit
cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40-50 …
cyclooxygenase activity, reduces the relative risk of colorectal cancer in humans by 40-50 …